Skip to Content




ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Therapeutic Categories

Treatment of neovascular (wet) age-related macular degeneration

Angiogenesis inhibitor

Treatment of diabetic retinopathy

Antineoplastic agent: Angiogenesis inhibitor

Chemical Name

des-432-lysine-[human vascular endothelial growth factor receptor 1-(103-204)-peptide (containing Ig-like C2-type 2 domain) fusion protein with human vascular endothelial growth factor receptor 2-(206-308)-peptide (containing Ig-like C2-type 3 domain frag (WHO )

Foreign Names

  • Afliberceptum (Latin)
  • Aflibercept (German)
  • Aflibercept (French)
  • Aflibercept (Spanish)

Generic Names

Brand Names

  • Eylea
    Bayer, Bosnia & Herzegowina; Bayer, Belgium; Bayer, Canada; Bayer, Denmark; Bayer, Spain; Bayer, United Kingdom; Bayer, Hong Kong; Bayer, Croatia (Hrvatska); Bayer, Hungary; Bayer, Ireland; Bayer, Iceland; Bayer, Italy; Bayer, South Korea; Bayer, Latvia; Bayer, New Zealand; Bayer, Poland; Bayer, Romania; Bayer, Sweden; Bayer, Slovakia; Bayer Australia Ltd, Australia; Bayer HealthCare, Finland; Bayer HealthCare, Singapore; Bayer Pharma, Austria; Bayer Pharma, Cyprus; Bayer Santé, France; Bayer Schering, Slovenia; Bayer Thai Co Ltd, Thailand; Bayer Vital, Germany; Bayer Yakuhin, Japan; GP Grenzach, Israel; Regeneron, United States
  • Eylia
    Bayer, Chile; Bayer, Colombia; Bayer, Guatemala; Bayer, El Salvador
  • Wetlia
    Bayer de México, Mexico
  • Zaltrap
    Sanofi, Germany; Sanofi, United Kingdom; Sanofi, Ireland; Sanofi, Sweden; Sanofi Aventis, Spain; Sanofi Oy, Finland; Sanofi-Aventis, Austria; Sanofi-Aventis, Bosnia & Herzegowina; Sanofi-Aventis, Belgium; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Denmark; Sanofi-Aventis, France; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Iceland; Sanofi-Aventis, Italy; Sanofi-Aventis, Norway; Sanofi-Aventis, Poland; Sanofi-Aventis, Slovakia


ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.